The start of America's longest war is the subject of the new movie "12 Strong." Navid Negahban joins Cheddar to discuss portraying a real-life character in this retelling of America teaming up with Afghan forces to fight the Taliban on horseback. The actor reveals how he went about taking on this challenging role, and how much he knew about the source material before shooting. The majority of the film is shot on horseback as the soldiers find unique ways to take on the rough Afghan terrain. Negahban discusses tearing his groin while training for the production. He also reveals what he learned about co-star Chris Hemsworth during their time on set together. Negahban plays the sultan in Disney's upcoming live-action "Aladdin" remake. The film is the subject of criticism over allegations of "white washing" and "browning up" actors with makeup. The actor weighs in on the controversy and shares his thoughts about how Hollywood is embracing diversity.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More